WuXi XDC
William (Weiming) Hu is a seasoned professional with extensive experience in strategic planning, investment, and market analysis across various industries. Currently serving as the Strategy & Investment Assistant Director in the CEO Office at WuXi Biologics and WuXi XDC, William is adept at conducting competitive market analysis and supporting strategic decisions at the executive level. Notable previous roles include TikTok Monetization Strategy Intern at 字节跳动, where in-depth research and analysis were conducted for business expansion, and Limited Partner at 南京鼎力天任企业管理合伙企业, successfully attracting investment for Seacross Pharmaceuticals. As a co-founder of Shenzhen Hongqi Technology Co., Ltd., William developed over 300 products and significantly increased sales through effective digital marketing strategies. William holds an MBA from China Europe International Business School and has furthered education at London Business School. Additionally, William holds dual Bachelor’s degrees in Economics and Finance from the University of Miami.
This person is not in any teams
This person is not in any offices
WuXi XDC
1 followers
WuXi XDC is a leading CRDMO focused on the global ADC and broader bioconjugate market and is dedicated to providing integrated services from concept development to commercialization. All services are provided from proximately located, state-of-the-art laboratories and manufacturing facilities, providing high efficiency and significant reduction of development timeline and costs. Our community of over 1000 skilled employees work across a global network to provide an open-access platform with the most comprehensive capabilities and technologies. WuXi XDC enables its biopharmaceutical partners to innovate, accelerate, and transform the development of the bioconjugate industry, to the benefit of patients worldwide.